American HealthCare Capital is pleased to introduce a dialysis business facility for sale in the Houston, Texas area. Established in 2016, the company is licensed by the Texas Health & Human Services Commission as an End Stage Renal Disease (ESRD) facility. The company’s services include home hemodialysis (HD) and home peritoneal dialysis (PD).
The dialysis company generated gross revenues of $714,612 and adjusted EBITDA of $62,376 (8.73%) in 2020. In 2021, gross revenues increased to 991,039 with adjusted EBITDA of $126,780 (12.79%). In 2022, gross revenues were $907,005 with adjusted EBITDA of $82,867 (9.14%). Through 6/30/23, the company generated gross revenues of $611,290 and adjusted EBITDA of $188,894 (30.9%), and they expect to gross $1.2 million by the end of 2023 with an adjusted EBITDA of $250,000. The improvement in profit margin in 2023 is attributed to an increase in patients and better insurance contracts.
The payer mix is 88% Commercial Insurance, 11% Medicare, and 1% Other. Insurance contracts include, but are not limited to, UHC WellMed Medicare Advantage, BCBS, Community Health Choice, Aetna Medicare Advantage, Ambetter-Superior, UHC, and BCBS-Ameriben. The dialysis business for sale currently serves 13 patients (9 PD and 4 HD).
There are 8 employees and contractors who are expected to remain with the dialysis company post-sale.
The seller will consider competitive offers.
If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.